July [●], 2019Merger Agreement • July 9th, 2019 • Altimmune, Inc. • Pharmaceutical preparations • Delaware
AGREEMENT AND PLAN OF MERGER AND REORGANIZATION BY AND AMONG ALTIMMUNE, INC., SPRINGFIELD MERGER SUB, INC., SPRINGFIELD MERGER SUB, LLC SPITFIRE PHARMA, INC. AND DAVID COLLIER, AS THE STOCKHOLDER REPRESENTATIVE DATED AS OF JULY 8, 2019Agreement and Plan of Merger and Reorganization • July 9th, 2019 • Altimmune, Inc. • Pharmaceutical preparations • Delaware
This Agreement and Plan of Merger and Reorganization (this “Agreement”), is made and entered into as of July 8, 2019 (the “Agreement Date”), by and among Altimmune, Inc., a Delaware corporation (“Parent”), Springfield Merger Sub, Inc., a Delaware corporation and a wholly-owned subsidiary of Parent (“Merger Sub I”), Springfield Merger Sub, LLC, a Delaware limited liability company and a wholly-owned subsidiary of Parent (“Merger Sub II” and, together with Merger Sub I, the “Merger Subs”), Spitfire Pharma, Inc., a Delaware corporation (the “Company”), and David Collier, in his capacity as the representative of the Company Stockholders (the “Stockholder Representative”).
